HesletL, NielsenJD, Nepper-ChristensenS. Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH)—a review of a new treatment paradigm. Biologics, 2012; 6:37–46.
2.
HesletL, NielsenJD, LeviM, SengeløvH, JohanssonPI. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care, 2006; 10:R177.
3.
ReiterJ, ColinAA, AndreanskyM, ShafieianM, NaresM, Ali-DinarT. Bronchoscopic instillation of activated recombinant factor vii to treat diffuse alveolar hemorrhage in pediatrics. Pediatr Allergy Immunol Pulmonol, 2015; 28:63–65.
4.
RoseRM, KobzikL, DushayK, et al.The effect of aerosolized recombinant human granulocyte macrophage colony-stimulating factor on lung leukocytes in nonhuman primates. Am Rev Respir Dis, 1992; 146:1279–1286.
5.
HesletL, AndersenJS, SengeløvH, DahlbäckB, Dalsgaard-NielsenJ. Inhalation of activated protein C: a possible new adjunctive intervention in acute respiratory distress syndrome. Biologics, 2007; 1:465–472.
6.
WaerhaugK, KuzkovVV, KuklinVN, et al.Inhaled aerosolised recombinant human activated protein C ameliorates endotoxin-induced lung injury in anaesthetised sheep. Crit Care, 2009; 13:R51.
7.
HesletL. Look on the “air side” in pneumonia. Crit Care Med, 2009; 37:774–775.
